Full-Time

Software Engineer

Web

Confirmed live in the last 24 hours

Science

Science

201-500 employees

Develops advanced biotech and high-tech products

Compensation Overview

$100k - $180k/yr

+ Equity

Junior, Mid

Alameda, CA, USA

Category
Web Development
Software Engineering
Required Skills
Web Development
Requirements
  • 2+ years of hands-on experience as a web software engineer, including significant depth in either backend or fullstack development.
  • Deep understanding of modern web applications design architecture, good API design patterns, and performance.
  • Adaptable and proactive in a fast‑paced, startup environment, taking ownership of projects and collaborating effectively.
  • Ability to act as your own product manager and understand the core requirements that make solutions effective.
  • A strong sense of when it's appropriate to address mounting technical debt and when to keep building new features.
Desired Qualifications
  • Our stack is Rails / React / Typescript / PostgreSQL. Experience with at least one of these technologies is a plus.
  • Experience with app deployment and devops.

Science.xyz develops specialized products and services in the biotech and high-tech sectors, focusing on areas like synthetic biology, stem cell research, microfabrication, and semiconductor devices. Their products are designed to meet the needs of clients such as academic institutions, research labs, and biotech companies. The company employs a skilled team of professionals, including scientists and engineers, to ensure their offerings are based on advanced research and development. Unlike many competitors, Science.xyz emphasizes collaboration and partnerships within the scientific community to enhance their product offerings. The goal of Science.xyz is to leverage scientific innovation to create valuable solutions that contribute to advancements in technology and biotechnology.

Company Size

201-500

Company Stage

Late Stage VC

Total Funding

$126M

Headquarters

Alameda, California

Founded

2021

Simplify Jobs

Simplify's Take

What believers are saying

  • Recent $100M funding boosts development of brain-computer interface technologies.
  • Acquisition of Pixium Vision SA technology enhances vision restoration product offerings.
  • Strategic location in Alameda, California, offers growth opportunities in tech and biotech markets.

What critics are saying

  • Increased competition from Neuralink may impact market share and growth potential.
  • Integration challenges and IP disputes may arise from Pixium Vision SA acquisition.
  • Neuron-based BCI development may face ethical and regulatory scrutiny, delaying launches.

What makes Science unique

  • Science Corp focuses on biohybrid neural interfaces, combining neurons with electronics.
  • The company develops neuron-based BCI methods, reducing brain damage compared to metal electrodes.
  • Science Corp's Synapse protocol enhances interoperability for neural interface devices.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Flexible Vacation

Paid Parental Leave

Paid Sick Leave

401(k) Retirement Plan

Dependent Care Flexible Spending Account

Flexible Spending Account

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

8%

2 year growth

11%
Longevity Technology
Apr 15th, 2025
Science Corp lands big funding round to advance BCI technology

New funding follows impressive vision restoration results in advanced AMD patients using retinal implant system.

Longevity Technology
Apr 15th, 2025
Science Corp raises $100M for BCI tech

Science Corp, a neurotech firm founded by Neuralink co-founder Max Hodak, has raised over $100 million in funding led by Khosla Ventures. This adds to the $186 million previously raised. The funding will accelerate the development and commercialization of their brain-computer interface technologies, including the PRIMA retinal implant system for vision restoration in advanced AMD patients. The system uses a wireless implant and specialized glasses to help patients perceive visual forms.

Bloomberg
Apr 14th, 2025
Neuralink Rival Science Corp. Raises $104 Million Led by Khosla

Science Corp., a technology company focused on the human brain started by Neuralink Corp. co-founder Max Hodak, has raised over $100 million in a funding round led by Khosla Ventures.

Chosun Ilbo
Feb 24th, 2025
Science Corporation develops neuron-based brain-computer interface to reduce damage

Science Corporation, a U.S. BCI company, is developing a method that secures more communication channels using neurons instead of inserting metal electrodes into the brain, while minimizing brain damage.

Science.xyz
Nov 23rd, 2024
Biohybrid neural interfaces: an old idea enabling a completely new space of possibilities

At Science, Science Corp. is developing a biohybrid probe technology using highly engineered, stem cell-derived neurons embedded in vitro in electronics and engrafted into the brain, forming new biological connections.